Urine Metabolites in the Diagnosis of Disease

Launched by LUVENTIX, INC. · Nov 25, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to diagnose different gastrointestinal (GI) diseases, such as colorectal cancer, small intestinal bacterial overgrowth (SIBO), Crohn's disease, and Celiac disease, by using urine samples. The researchers aim to develop a non-invasive test that can help identify these conditions without needing more invasive procedures. They will collect urine samples from participants and use advanced computer technology to analyze the samples and create models that can tell the difference between healthy individuals and those with specific GI diseases.

To participate in this study, you need to be at least 18 years old and willing to provide a one-time urine sample. You should also be able to understand the study and give consent to participate. However, if you are pregnant or have a medical condition that could affect your safety in the study, you may not be eligible. Participants can expect to contribute to important research that could lead to better diagnosis methods for GI diseases, while also helping scientists understand how well this new urine test works.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years of age at time of enrollment.
• • Able and willing to provide a one-time urine sample and comply with all study procedures for the study.
• • Able to understand the study procedures, able to provide consent to participate in the study, and willing to authorize release of relevant protected health information by consenting to a HIPAA medical release form.
• Exclusion Criteria:
• • Known to be pregnant.
• • A medical condition which, in the opinion of the Investigator and/or Sponsor, should preclude enrollment in the study.